肝臓がん患者の治療における手術（肝動脈化学療法併用または非併用）

基本情報

NCT ID

NCT00238160

ステータス

取り下げ

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

0

治験依頼者名

National Cancer Institute (NCI)

概要

RATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving drugs directly into the arteries around the tumor may kill more tumor cells. Giving chemotherapy after surgery may kill any remaining tumor cells. It is not yet known whether surgery and hepatic arterial chemotherapy are more effective than surgery alone in treating patients with liver cancer that has spread to the portal vein. PURPOSE: This randomized phase III trial is studying surgery and hepatic arterial chemotherapy to see how well they work compared to surgery alone in treating patients with liver cancer that has spread to the portal vein.

対象疾患

介入

依頼者（Sponsor）

実施施設 (4)